Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Taiji Watanabe is active.

Publication


Featured researches published by Taiji Watanabe.


Journal of Controlled Release | 2009

Protective effects of the complex between manganese porphyrins and catalase-poly(ethylene glycol) conjugates against hepatic ischemia/reperfusion injury in vivo.

Tomochika Hanawa; Shoichiro Asayama; Taiji Watanabe; Shigeru Owada; Hiroyoshi Kawakami

The complex between manganese (Mn) porphyrins and catalase-poly(ethylene glycol) (PEG) conjugates has been designed for the protective effect against hepatic ischemia/reperfusion injury in vivo. The resulting Mn-porphyrin/catalase-PEG complex with dual enzymatic activity of superoxide dismutase (SOD) and catalase enhanced the blood circulation. The spin reduction rate in the rats treated with the Mn-porphyrin/catalase-PEG complex was significantly higher than that in the untreated rats and almost equal to that in the sham group rats. Furthermore, the Mn-porphyrin/catalase-PEG complex significantly decreased the serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. These results suggest that the Mn-porphyrin/catalase-PEG complex exhibited the antioxidative activity to protect hepatic ischemia/reperfusion injury in vivo.


Surgery Today | 2010

Mixed acinar-endocrine carcinoma of the pancreas with intraductal growth into the main pancreatic duct: Report of a case

Shinjiro Kobayashi; Takeshi Asakura; Nobuyuki Ohike; Takeharu Enomoto; Joe Sakurai; Satoshi Koizumi; Taiji Watanabe; Hiroshi Nakano; Takehito Otsubo

The patient was a 75-year-old asymptomatic man, in whom a tumor mass in the pancreatic tail had been found 6 months earlier. Computed tomography revealed a mass 7 cm in diameter, and an enhancement with contrast medium was observed at the periphery and partially inside the mass, but not in most parts of the tumor. Endoscopic retrograde cholangiopancreatography showed a filling defect in the main pancreatic duct. A distal pancreatectomy was performed because of the possibility of a malignant tumor. The tumor consisted of a lobular invasive growth component and a component with intraductal growth into the main pancreatic duct, and histologically the tumor cells had solid acinar to partially trabecular/tubular patterns. Trypsin (an acinic cell marker) expression was widely observed, followed by the expression of chromogranin A (an endocrine cell marker) in about 30% of the tumor cells. The tumor was diagnosed as mixed acinar-endocrine carcinoma according to the WHO classification.


European Surgical Research | 2007

A new chemosensitivity assay for ascites tumor cells using a thermoreversible gelation polymer as a culture medium and the observed clinical responses.

Akiko Isogai; Masaki Nagaya; Hiromitu Matsuoka; Taiji Watanabe; Satoshi Tsukikawa; Sunao Kubota

Background/Aim: Ascites tumor cells from patients with peritonitis carcinomatosa were tested for cis-diamminedichloroplatinum (CDDP) sensitivity. The patients were divided into CDDP-sensitive and resistant groups. Survival and time to progression (TTP) rates were compared. Materials and Methods: 18 peritonitis carcinomatosa patients with class V ascites based on cytologic diagnosis were enrolled in this study. Chemosensitivity testing of the ascites tumor cells was done to determine their sensitivity to CDDP using a three-dimensional culture matrix of thermoreversible gelation polymer (TGP). CDDP at a dose calculated to achieve ascitic fluid drug levels equivalent to the IC50 was given intraperitoneally to 12 CDDP-sensitive patients and 6 CDDP-resistant patients. Results: Both the median survival time and the median TTP were significantly longer in CDDP-sensitive patients than in CDDP-resistant patients (survival time 105 vs. 13 days, p = 0.019; TTP 90 vs. 5 days, p = 0.029). Conclusion: The results indicate the potential feasibility of controlling ascites in cancer patients in whom a maximal dose effect can be achieved with a minimal dose of chemotherapy.


World Journal of Surgical Oncology | 2007

A rare case of concomitant huge exophytic gastrointestinal stromal tumor of the stomach and Kasabach-Merritt phenomenon

Taiji Watanabe; Kohei Segami; Takahiro Sasaki; Hatsuya Kawashima; Takeharu Enomoto; Yuji Jinnouchi; Satoshi Koizumi; Naotaka Tobe; Joh Sakurai; Tsukasa Shimamura; Tadashi Suda; Takeshi Asakura; Hiroshi Nakano; Tanaka Ichiroh; Takehito Otsubo

BackgroundWe report an extremely rare case of concomitant huge exophytic GIST of the stomach and Kasabach-Merritt phenomenon (KMP).Case presentationThe patient was a 67-year-old man experiencing abdominal distension since September 2006. A physical examination revealed a 25 × 30 cm hard mass that was palpable in the middle and lower left abdomen minimal intrinsic mobility and massive ascites. Since the admitted patient was diagnosed with DIC, surgery could not be performed. The patient received a platelet transfusion and the DIC was treated. Due to this treatment, the platelet count recovered to 7.0 × 104; tumor resection was performed at 16 days after admission. Laparotomy revealed a huge extraluminal tumor arising from the greater curvature of the stomach that measured 25 × 30 cm and had not ruptured into the peritoneal cavity or infiltrated other organs. Partial gastric resection was performed. The resected mass measured 25 × 25 × 20 cm. In cross section, the tumor appeared hard and homogenous with a small polycystic area. Histopathology of the resected specimen showed large spindle cell GIST with >5/50 HPF (high-power field) mitotic activity. The postoperative course was uneventful, and the coagulopathy improved rapidly.ConclusionSince the characteristic of tumor in this case was hypervascularity with bleeding and necrotic lesions, coagulopathy was thought to be caused by the trapping of platelets within a large vasculized tumor mass.


European Surgical Research | 2008

Modification of the Hepatic Mitochondrial Proteome in Response to Ischemic Preconditioning following Ischemia-Reperfusion Injury of the Rat Liver

R. Oshima; Hiroshi Nakano; M. Katayama; J. Sakurai; Wenwen Wu; S. Koizumi; T. Asano; Taiji Watanabe; T. Asakura; Tomohiko Ohta; T. Otsubo

Background/Aim: Ischemic preconditioning (IPC) may reduce hepatic ischemia-reperfusion (IR) injury, but efficacy of IPC on mitochondrial proteome is not demonstrated. We investigated how IPC modifies the mitochondrial proteome after IR injury. Methods: Rats were subjected to 25 min of portal triad crossclamping (IR group, n = 8). In the IPC group (n = 8), 10 min of temporal portal triad clamping was performed before 25 min of portal clamping. Samples were obtained after 24 h. The mitochondrial inner-membrane potential was measured by the uptake of a lipophilic cationic carbocyanine probe and mitochondrial proteome was also investigated using 2-dimensional differential in-gel electrophoresis and liquid chromatography-tandem mass spectrometry. Results: Mitochondrial inner-membrane potential and glutathione were lower and serum transaminase was higher in the IPC group than in the IR group. The mitochondrial precursor of aldehyde dehydrogenase 2 and α-methylacyl-CoA-racemase were upregulated in the IPC group in comparison to the IR group. In contrast, protein disulfide-isomerase A3 precursor, 60S acid ribosomal protein P0, carbonic anhydrase 3 and superoxide dismutase were significantly more downregulated in the IPC group than in the IR group. Conclusions: A hepatoprotective effect by IPC was not shown; however, IPC caused significant up- or downregulation of several mitochondrial proteins.


Journal of Surgical Research | 2005

The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice.

Taiji Watanabe; Sunao Kubota; Masaki Nagaya; Shoichi Ozaki; Hiroko Nagafuchi; Katsuya Akashi; Yasuhiko Taira; Satoshi Tsukikawa; Shigeru Oowada; Suehiro Nakano


World Journal of Surgery | 2014

Perioperative Care with Fast-Track Management in Patients Undergoing Pancreaticoduodenectomy

Shinjiro Kobayashi; Ryuiti Ooshima; Satoshi Koizumi; Masafumi Katayama; Joe Sakurai; Taiji Watanabe; Hiroshi Nakano; Toshihide Imaizumi; Takehito Otsubo


Biological & Pharmaceutical Bulletin | 2010

Effects of a Calcium-Channel Blocker (CV159) on Hepatic Ischemia/Reperfusion Injury in Rats: Evaluation with Selective NO/pO2 Electrodes and an Electron Paramagnetic Resonance Spin-Trapping Method

Keizo Hataji; Taiji Watanabe; Shigeru Oowada; Masaki Nagaya; Masato Kamibayashi; Eiichi Murakami; Hiroyoshi Kawakami; Atsuko Ishiuchi; Toshio Kumai; Hiroshi Nakano; Shinichi Kobayashi; Takehito Otsubo


Transplantation Proceedings | 2007

Protective effects of MnM2Py4P and Mn-salen against small bowel ischemia/reperfusion injury in rats using an in vivo and an ex vivo electron paramagnetic resonance technique with a spin probe.

Taiji Watanabe; S. Owada; Hiromichi Kobayashi; H. Kawakami; S. Nagaoka; E. Murakami; Atsuko Ishiuchi; Takeharu Enomoto; Yuji Jinnouchi; Joh Sakurai; Naotaka Tobe; Satoshi Koizumi; Tsukasa Shimamura; Takeshi Asakura; Hiroshi Nakano; Takehito Otsubo


Journal of Surgical Research | 2008

The Role of the New Ca2+ Antagonist, CV159, in Hepatic I/R Injury—The Evaluation of Hepatic Organ Reducing Activity Using In Vivo and Ex Vivo EPR

Taiji Watanabe; Shigeru Oowada; Hiromichi Kobayashi; Masato Kamibayashi; Atsuko Ishiuchi; Yuji Jinnouchi; Satoshi Koizumi; Takayuki Asano; Tsukasa Shimamura; Takeshi Asakura; Hiroshi Nakano; Sunao Kubota; Takehito Otsubo

Collaboration


Dive into the Taiji Watanabe's collaboration.

Top Co-Authors

Avatar

Takehito Otsubo

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satoshi Koizumi

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Takeshi Asakura

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hiromichi Kobayashi

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Takayuki Asano

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Shigeru Oowada

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Sunao Kubota

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yuji Jinnouchi

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Joe Sakurai

St. Marianna University School of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge